HomeALDX • NASDAQ
Aldeyra Therapeutics Inc
add
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 10.43M | 11.00% |
Net income | -9.93M | -22.86% |
Net profit margin | — | — |
Earnings per share | -0.17 | -21.43% |
EBITDA | -10.37M | -11.07% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 90.06M | 8.45% |
Total assets | 93.20M | -34.04% |
Total liabilities | 29.60M | 6.15% |
Total equity | 63.60M | — |
Shares outstanding | 59.90M | — |
Price to book | 2.92 | — |
Return on assets | -26.36% | — |
Return on capital | -31.51% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -9.93M | -22.86% |
Cash from operations | -12.47M | -25.04% |
Cash from investing | 7.29M | 124.00% |
Cash from financing | 1.00M | 5,412.67% |
Net change in cash | -4.18M | 89.64% |
Free cash flow | -8.28M | 85.73% |
Previous close
$3.09
Day range
$3.01 - $3.19
Year range
$1.14 - $7.19
Market cap
189.27M USD
Avg Volume
1.04M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2004
Headquarters
Website
Employees
8
